Beyond Empowerment in Rheumatology Care
J Rheumatol. 2022 May 15:jrheum.220348. doi: 10.3899/jrheum.220348. Online ahead of print.ABSTRACTIn this issue of The Journal of Rheumatology, Carluzzo et al1 explored different factors that contribute to the empowerment of individuals with arthritis. The study used data obtained from 12,560 US participants in the Live Yes! INSIGHTS program, based on sociodemographic information and patient-reported outcome measures (PROMs) about physical and mental health, emotional support, and empowerment.PMID:35569826 | DOI:10.3899/jrheum.220348 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - May 15, 2022 Category: Rheumatology Authors: Amaranta Manrique de Lara Ingris Pel áez-Ballestas Source Type: research

Some Key Issues Relating to the Reporting and Interpretation of Time-to-event Data
J Rheumatol. 2022 May 15:jrheum.220053. doi: 10.3899/jrheum.220053. Online ahead of print.ABSTRACTGriffiths et al recently reported that in a cohort of Australian patients with ankylosing spondylitis included in the Optimising Patient outcomes in Australian RheumatoLogy (OPAL) dataset, the median persistence (persistence defined as the time to discontinuation of treatment) was longest for patients treated with golimumab (GOL) in all lines of therapy, and shortest for those treated with etanercept (ETN).1 In drawing this conclusion, the authors have overlooked some statistical aspects relating to the reporting of time-to-ev...
Source: Journal of Rheumatology - May 15, 2022 Category: Rheumatology Authors: I Manjula Schou Source Type: research

Impact of Axial Spondyloarthritis on Quality of Life: Results From the European Map of Axial Spondyloarthritis (EMAS) Study in France
J Rheumatol. 2022 May 15:jrheum.210864. doi: 10.3899/jrheum.210864. Online ahead of print.ABSTRACTThe effect of axial spondyloarthritis (axSpA) on patients' quality of life (QOL) has been well assessed in terms of body structures and functions, but literature is scarce in terms of social interactions and activities, work, and fears related to social interactions or activities.1.PMID:35569828 | DOI:10.3899/jrheum.210864 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - May 15, 2022 Category: Rheumatology Authors: Joanna Kedra Pascal Claudepierre Ren é-Marc Flipo Marco Garrido-Cumbrera Fran çoise Alliot-Launois Emilie Desfleurs Laurent Grange Laure Gossec Source Type: research

Spondyloarthritis Among Patients With Uveitis: Can We Improve Referral Pathways?
J Rheumatol. 2022 May 15:jrheum.220263. doi: 10.3899/jrheum.220263. Online ahead of print.ABSTRACTDelays in diagnosis remain a major gap in the care of patients with axial spondyloarthritis (axSpA). Despite efforts to improve awareness among family physicians and nonrheumatologist specialists, the average duration from onset of symptoms to diagnosis of axSpA is approximately 8 years,1 which is one of the longest in rheumatology. Such delays in diagnosis are associated with late initiation of therapy and worse disease outcomes.PMID:35569829 | DOI:10.3899/jrheum.220263 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - May 15, 2022 Category: Rheumatology Authors: Lihi Eder Source Type: research

Is it time to bring back knee washout?
J Rheumatol. 2022 May 15:jrheum.211132. doi: 10.3899/jrheum.211132. Online ahead of print.ABSTRACTWashout of knee joint contents, whether by arthotomy, arthroscopy, or percutaneous methods, can remove phlogistic material contributing to the problem at hand. Observations dating from the turn of the last century coupled with multiple trials suggest such an intervention can be useful in the management of osteoarthritis, inflammatory arthropathies, crystal arthritis and septic arthritis. We suggest that this intervention - applicable at the bedside with minimal cost, preparation, or expertise - be reconsidered as an adjunct in...
Source: Journal of Rheumatology - May 15, 2022 Category: Rheumatology Authors: Robert W Ike Kenneth C Kalunian Source Type: research

Vasculitis: What Have We Learned in the Last 50 Years?
J Rheumatol. 2022 May 15:jrheum.220207. doi: 10.3899/jrheum.220207. Online ahead of print.ABSTRACTRealizing in the fall of 2021 that I had started medical school exactly 50 years ago, on September 7, 1971, I thought that it would be interesting for the 2022 Dunlop-Dottridge Lecture to briefly review what we knew about vasculitis prior to 1971 and then reflect on what we have learned since.PMID:35569831 | DOI:10.3899/jrheum.220207 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - May 15, 2022 Category: Rheumatology Authors: Simon Carette Source Type: research

Management of calcinosis cutis in rheumatic diseases
J Rheumatol. 2022 May 15:jrheum.211393. doi: 10.3899/jrheum.211393. Online ahead of print.ABSTRACTCalcinosis (hydroxyapatite and calcium phosphate crystal deposition) within the extracellular matrix of the dermis and subcutaneous tissue is a frequent manifestation of adult and pediatric systemic autoimmune rheumatic diseases, specifically systemic sclerosis, dermatomyositis, mixed connective tissue disease and systemic lupus erythematosus. In this article, we review classification of calcinosis, highlight mechanisms that may contribute to the pathogenesis of calcinosis and summarize the evidence evaluating non-pharmacologi...
Source: Journal of Rheumatology - May 15, 2022 Category: Rheumatology Authors: Hadiya Elahmar Brian M Feldman Sindhu R Johnson Source Type: research

Dr. Griffiths et al reply
J Rheumatol. 2022 May 15:jrheum.220120. doi: 10.3899/jrheum.220120. Online ahead of print.ABSTRACTWe thank Dr Schou for her insightful comments.1 The interpretation of data from an observational study such as this is complex, and the conclusions are by necessity less robust than in a randomized controlled trial.PMID:35569833 | DOI:10.3899/jrheum.220120 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - May 15, 2022 Category: Rheumatology Authors: Jo Leadbetter Hedley Griffiths Source Type: research

Personally-Generated Quality of Life Outcomes in Adults with Juvenile Idiopathic Arthritis
CONCLUSION: Physical activity, work/school, fatigue and self-image were frequently nominated areas affecting QOL in young adults with JIA. The PGI included aspects of QOL not covered in standardized measures.PMID:35569834 | DOI:10.3899/jrheum.211245 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - May 15, 2022 Category: Rheumatology Authors: Anita Tollisen Anne Marit Selvaag Astrid Aasland Trude Ingebrigtsen Joachim Sagen Anners Lerdal Berit Flat ø Source Type: research

Beyond Empowerment in Rheumatology Care
J Rheumatol. 2022 May 15:jrheum.220348. doi: 10.3899/jrheum.220348. Online ahead of print.ABSTRACTIn this issue of The Journal of Rheumatology, Carluzzo et al1 explored different factors that contribute to the empowerment of individuals with arthritis. The study used data obtained from 12,560 US participants in the Live Yes! INSIGHTS program, based on sociodemographic information and patient-reported outcome measures (PROMs) about physical and mental health, emotional support, and empowerment.PMID:35569826 | DOI:10.3899/jrheum.220348 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - May 15, 2022 Category: Rheumatology Authors: Amaranta Manrique de Lara Ingris Pel áez-Ballestas Source Type: research

Some Key Issues Relating to the Reporting and Interpretation of Time-to-event Data
J Rheumatol. 2022 May 15:jrheum.220053. doi: 10.3899/jrheum.220053. Online ahead of print.ABSTRACTGriffiths et al recently reported that in a cohort of Australian patients with ankylosing spondylitis included in the Optimising Patient outcomes in Australian RheumatoLogy (OPAL) dataset, the median persistence (persistence defined as the time to discontinuation of treatment) was longest for patients treated with golimumab (GOL) in all lines of therapy, and shortest for those treated with etanercept (ETN).1 In drawing this conclusion, the authors have overlooked some statistical aspects relating to the reporting of time-to-ev...
Source: Journal of Rheumatology - May 15, 2022 Category: Rheumatology Authors: I Manjula Schou Source Type: research

Impact of Axial Spondyloarthritis on Quality of Life: Results From the European Map of Axial Spondyloarthritis (EMAS) Study in France
J Rheumatol. 2022 May 15:jrheum.210864. doi: 10.3899/jrheum.210864. Online ahead of print.ABSTRACTThe effect of axial spondyloarthritis (axSpA) on patients' quality of life (QOL) has been well assessed in terms of body structures and functions, but literature is scarce in terms of social interactions and activities, work, and fears related to social interactions or activities.1.PMID:35569828 | DOI:10.3899/jrheum.210864 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - May 15, 2022 Category: Rheumatology Authors: Joanna Kedra Pascal Claudepierre Ren é-Marc Flipo Marco Garrido-Cumbrera Fran çoise Alliot-Launois Emilie Desfleurs Laurent Grange Laure Gossec Source Type: research

Spondyloarthritis Among Patients With Uveitis: Can We Improve Referral Pathways?
J Rheumatol. 2022 May 15:jrheum.220263. doi: 10.3899/jrheum.220263. Online ahead of print.ABSTRACTDelays in diagnosis remain a major gap in the care of patients with axial spondyloarthritis (axSpA). Despite efforts to improve awareness among family physicians and nonrheumatologist specialists, the average duration from onset of symptoms to diagnosis of axSpA is approximately 8 years,1 which is one of the longest in rheumatology. Such delays in diagnosis are associated with late initiation of therapy and worse disease outcomes.PMID:35569829 | DOI:10.3899/jrheum.220263 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - May 15, 2022 Category: Rheumatology Authors: Lihi Eder Source Type: research

Is it time to bring back knee washout?
J Rheumatol. 2022 May 15:jrheum.211132. doi: 10.3899/jrheum.211132. Online ahead of print.ABSTRACTWashout of knee joint contents, whether by arthotomy, arthroscopy, or percutaneous methods, can remove phlogistic material contributing to the problem at hand. Observations dating from the turn of the last century coupled with multiple trials suggest such an intervention can be useful in the management of osteoarthritis, inflammatory arthropathies, crystal arthritis and septic arthritis. We suggest that this intervention - applicable at the bedside with minimal cost, preparation, or expertise - be reconsidered as an adjunct in...
Source: Journal of Rheumatology - May 15, 2022 Category: Rheumatology Authors: Robert W Ike Kenneth C Kalunian Source Type: research

Vasculitis: What Have We Learned in the Last 50 Years?
J Rheumatol. 2022 May 15:jrheum.220207. doi: 10.3899/jrheum.220207. Online ahead of print.ABSTRACTRealizing in the fall of 2021 that I had started medical school exactly 50 years ago, on September 7, 1971, I thought that it would be interesting for the 2022 Dunlop-Dottridge Lecture to briefly review what we knew about vasculitis prior to 1971 and then reflect on what we have learned since.PMID:35569831 | DOI:10.3899/jrheum.220207 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - May 15, 2022 Category: Rheumatology Authors: Simon Carette Source Type: research